Medications for Amyotrophic Lateral Sclerosis

5 results

  • edaravone

    (edaravone)
    XGen Pharmaceuticals DJB, Inc.
    Edaravone injection is indicated for the treatment of amyotrophic lateral sclerosis (ALS).

  • qalsody

    (tofersen)
    Biogen Inc.
    QALSODY is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults with a superoxide dismutase 1 (SOD1) gene mutation. Approval is based on reduced plasma neurofilament light chain (NfL) levels, with continued approval pending verification of clinical benefit from further trials.

  • radicava

    (EDARAVONE)
    Mitsubishi Tanabe Pharma America, Inc.
    RADICAVA and RADICAVA ORS are indicated for the treatment of amyotrophic lateral sclerosis (ALS).

  • relyvrio

    (sodium phenylbutyrate/taurursodiol)
    Amylyx Pharmaceuticals Inc
    RELYVRIO is indicated for the treatment of amyotrophic lateral sclerosis (ALS) in adults.

  • tiglutik

    (Riluzole)
    EDW PHARMA, INC
    TIGLUTIK is indicated for the treatment of amyotrophic lateral sclerosis (ALS).